Middle East and Africa Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Broiler, Layer, and Breeder), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others), Dosage Form (Liquid vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease [Newcastle Disease, Avian Influenza, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Salmonellosis, and Others], Route of Administration [Drinking Water (D/W) and Spray, Intramuscular (I/M), Subcutaneous (S/C), and Others], and End User (Poultry Farms and Hatcheries, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
The Middle East & Africa poultry vaccines market is expected to reach US$ 67.201 million by 2028 from US$ 53.162 million in 2021. The market is estimated to grow at a CAGR of 3.4% from 2021 to 2028.
The Middle East & Africa poultry vaccines market is characterized by various small and big companies.The market players are adopting the strategies such as new product launches, regional expansion, and technological advancements to increase their market share. Market players are investing in R&D to develop advanced technologies and gain more revenue share. For instance, in July 2019, CEVA SANTÉ ANIMALE Company and IDT Biologika GmbH announced their successful completion of the acquisition of IDT's veterinary biopharmaceutical as well as R&D activities by CEVA SANTÉ ANIMALE. Similarly, in 2020, Merck Poultry Vaccines signed a partnership agreement with Automazioni VX, Inc. (US). The partnership aimed to introduce Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be combined with Merck Animal Health's Innovax range of vaccines, which is used to protect against infectious poultry diseases. Further, in January 2020, Boehringer Ingelheim's and Poultry Vaccines business launched a vaccine named VAXXITEK HVT+IBD+ND to protect poultry from three diseases and provide a strong immune foundation and optimized protection against Marek's disease, infectious bursal disease (classic and variant types) and Newcastle disease. The market players are also likely to enter strategic ventures to bring in new products. For instance, in June 2018, MSD Animal Health, a Merck & Co., Inc. subsidiary, entered into a partnership agreement with Vinovo B.V. This synergistic partnership combined a broad vaccine portfolio with a novel delivery system to protect against highly infectious poultry diseases efficiently and effectively. The Middle East & Africa poultry vaccines market is expected to grow at a good CAGR during the forecast period.
Middle East & Africa Poultry Vaccines Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Poultry Vaccines Market Segmentation
The Middle East & Africa poultry vaccines market is segmented based on type, technology, dosage form, disease, route of administration, end user, and country. Based on type, the market is segmented into broiler, layer, and breeder. The breeder segment dominated the MEA poultry vaccines market in 2020. In terms of technology, the market is segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment dominated the MEA poultry vaccines market in 2020. Based on dosage form, the market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment dominated the MEA poultry vaccines market in 2020. Based on disease, the market is segmented into Newcastle disease, avian influenza, Marek's disease, infectious bronchitis (IB), infectious bursal disease (IBD), salmonellosis, and others. The Newcastle disease dominated the MEA poultry vaccines market in 2020. Based on route of administration, the market is segmented into drinking water (d/w) and spray, intramuscular (i/m), subcutaneous (s/c), and others. The drinking water (d/w) and spray segment dominated the MEA poultry vaccines market in 2020. Based on end user, the market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatchery segment dominated the MEA poultry vaccines market in 2020. Based on country, the Middle East & Africa poultry vaccines market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa poultry vaccines market in 2020.
Boehringer Ingelheim International GmbH, Zoitis Inc., Ceya Santae Animale, BIOVAC, PHIBRO ANIMAL HEALTH CORPORATION, Hester Biosciences Limited, Dechra Pharmaceutical Plc, Elanco, and Merck Animal Health are among the leading companies in the Middle East & Africa poultry vaccines market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Poultry Vaccines Market – By Type
1.3.2 MEA Poultry Vaccines Market – By Technology
1.3.3 MEA Poultry Vaccines Market – By Dosage Form
1.3.4 MEA Poultry Vaccines Market – By Disease
1.3.5 MEA Poultry Vaccines Market – By Route of Administration
1.3.6 MEA Poultry Vaccines Market – By End User
1.3.7 MEA Poultry Vaccines Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Poultry Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
4.3 Experts Opinion
5. MEA Poultry Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Diseases in Poultry
5.1.2 Increasing Demand for Healthy Poultry Food
5.2 Market Restraints
5.2.1 Failure of Vaccines in Poultry Production
5.3 Market Opportunities
5.3.1 Rising Growth of Market in Untapped Economies
5.4 Future Trends
5.4.1 Key Business Strategies to Enhance Market Growth in Future
5.5 Impact Analysis
6. Poultry Vaccines Market– MEA Analysis
6.1 MEA Poultry Vaccines Market Revenue Forecast and Analysis
6.1.1 Poultry Vaccines Market Revenue Forecast and Analysis
7. MEA Poultry Vaccines Market Analysis – By Type
7.1 Overview
7.2 Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)
7.3 Broiler
7.3.1 Overview
7.3.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Layer
7.4.1 Overview
7.4.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Breeder
7.5.1 Overview
7.5.2 Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. MEA Poultry Vaccines Market Analysis – By Technology
8.1 Overview
8.2 Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Recombinant Vaccines
8.5.1 Overview
8.5.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9. MEA Poultry Vaccines Market Analysis – By Dosage Form
9.1 Overview
9.2 Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)
9.3 Liquid Vaccines
9.3.1 Overview
9.3.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Freeze-Dried Vaccines
9.4.1 Overview
9.4.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Dust/Powdered Vaccines
9.5.1 Overview
9.5.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10. Poultry Vaccines Market Analysis – By Disease
10.1 Overview
10.2 Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)
10.3 Infectious Bronchitis
10.3.1 Overview
10.3.2 Infectious Bronchitis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Avian Influenza
10.4.1 Overview
10.4.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Marek's Disease
10.5.1 Overview
10.5.2 Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Bursal Disease
10.6.1 Overview
10.6.2 Infectious Bursal Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Salmonellosis
10.7.1 Overview
10.7.2 Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Newcastle Disease
10.8.1 Overview
10.8.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11. MEA Poultry Vaccines Market Analysis – By Route of Administration
11.1 Overview
11.2 Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)
11.3 Drinking water (D/W) & Spray
11.3.1 Overview
11.3.2 Drinking water (D/W) & Spray: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Intramuscular (I/M)
11.4.1 Overview
11.4.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Subcutaneous (S/C)
11.5.1 Overview
11.5.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11.6 Others
11.6.1 Overview
11.6.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12. MEA Poultry Vaccines Market Analysis – By End User
12.1 Overview
12.2 Poultry Vaccines Market Share, by End User, 2021 and 2028, (%)
12.3 Veterinary Hospitals
12.3.1 Overview
12.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.4 Poultry Vaccination Centers & Clinics
12.4.1 Overview
12.4.2 Poultry Vaccination Centre: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.5 Poultry Farms and Hatchery
12.5.1 Overview
12.5.2 Poultry Farms and Hatchery: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13. MEA Poultry Vaccines Market – Country Analysis
13.1 Middle East & Africa: Poultry Vaccines Market
13.1.1 Overview
13.1.2 Middle East & Africa: Poultry Vaccines Market, by Country, 2021 & 2028 (%)
13.1.2.1 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.1.1 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.1.2 Saudi Arabia: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
13.1.2.1.3 Saudi Arabia: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
13.1.2.1.4 Saudi Arabia: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
13.1.2.1.5 Saudi Arabia: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
13.1.2.1.6 Saudi Arabia: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
13.1.2.1.7 Saudi Arabia: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
13.1.2.2 UAE: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.2.1 UAE: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.2.2 UAE: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
13.1.2.2.3 UAE: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
13.1.2.2.4 UAE: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
13.1.2.2.5 UAE: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
13.1.2.2.6 UAE: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
13.1.2.2.7 UAE: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
13.1.2.3 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.3.1 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.3.2 South Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
13.1.2.3.3 South Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
13.1.2.3.4 South Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
13.1.2.3.5 South Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
13.1.2.3.6 South Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
13.1.2.3.7 South Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
13.1.2.4 Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.4.1 Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
13.1.2.4.2 Rest of Middle East & Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
13.1.2.4.3 Rest of Middle East & Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
13.1.2.4.4 Rest of Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
13.1.2.4.5 Rest of Middle East & Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
13.1.2.4.6 Rest of Middle East & Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
13.1.2.4.7 Rest of Middle East & Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
14. Industry Landscape
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. Company Profiles
15.1 Boehringer Ingelheim International GmbH
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Zoetis Inc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Ceva Santé Animale
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BIOVAC
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 PHIBRO ANIMAL HEALTH CORPORATION
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Hester Biosciences Limited
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Dechra Pharmaceuticals PLC
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Elanco
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Merck Animal Health
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
Table 2. Saudi Arabia: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
Table 3. Saudi Arabia: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
Table 4. Saudi Arabia: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
Table 5. Saudi Arabia: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
Table 6. Saudi Arabia: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
Table 7. UAE: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
Table 8. UAE: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
Table 9. UAE: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
Table 10. UAE: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
Table 11. UAE: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
Table 12. UAE: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
Table 13. South Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
Table 14. South Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
Table 15. South Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
Table 16. South Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
Table 17. South Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
Table 18. South Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
Table 19. Rest of Middle East & Africa: Poultry Vaccines Market, by Type, 2019–2028 (USD Million)
Table 20. Rest of Middle East & Africa: Poultry Vaccines Market, by Technology, 2019–2028 (USD Million)
Table 21. Rest of Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2019–2028 (USD Million)
Table 22. Rest of Middle East & Africa: Poultry Vaccines Market, by Disease, 2019–2028 (USD Million)
Table 23. Rest of Middle East & Africa: Poultry Vaccines Market, by Route of Administration, 2019–2028 (USD Million)
Table 24. Rest of Middle East & Africa: Poultry Vaccines Market, by End User, 2019–2028 (USD Million)
Table 25. Organic Developments in the Poultry Vaccine Market
Table 26. Inorganic Developments in the Poultry Vaccine Market
Table 27. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Poultry Vaccines Market Segmentation
Figure 2. MEA Poultry Vaccines Market, By Country
Figure 3. MEA Poultry Vaccines Market Overview
Figure 4. Breeder Segment Held Largest Share of Type Segment in MEA Poultry Vaccines Market
Figure 5. MEA is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. MEA Experts Opinion
Figure 8. MEA Poultry Vaccines Market: Impact Analysis of Drivers and Restraints
Figure 9. MEA Poultry Vaccines Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. MEA Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)
Figure 11. MEA Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. MEA Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. MEA Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. MEA Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)
Figure 15. MEA Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. MEA Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. MEA Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. MEA Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. MEA Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)
Figure 20. MEA Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. MEA Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)
Figure 24. MEA Infectious Bronchitis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. MEA Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Infectious Bursal Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. MEA Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. MEA Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. MEA Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. MEA Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)
Figure 32. MEA Drinking water (D/W) & spray: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. MEA Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. MEA Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. MEA Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. MEA Poultry Vaccines Market Share, by End User, 2021 and 2028 (%)
Figure 37. MEA Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. MEA Poultry Vaccination Centre: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. MEA Poultry Farms and Hatchery: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Middle East and Africa: Poultry Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 41. Middle East & Africa: Poultry Vaccines Treatment Market, by Country, 2021 & 2028 (%)
Figure 42. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. UAE: Poultry Vaccines Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2028 (USD Million)
1.Boehringer Ingelheim Intrnational GmbH.
2.Zoitis Inc.
3.Ceya Santae Animale.
4.BIOVAC.
5.PHIBRO ANIMAL HEALTH CORPORATION.
6.Hester Biosciences Limited.
7.Dechra Pharmaceutical Plc.
8. Elanco.
9.Merck Animal Health.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Poultry Vaccines market forecast.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa Poultry Vaccines market forecast, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the poultry vaccines market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.